Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

CESC - 7% dividend yield + higher ESG rating - ICICI Securities

Posted On: 2021-01-14 06:22:42 (Time Zone: Arizona, USA)


CESC reported good earnings growth for its consolidated business in Q3FY21, in line with our estimates. Standalone / consolidated PAT came in at Rs1.8bn / Rs3.3bn (3.4% / 21.3% YoY) mainly due to good profit growth for Chandrapur, Crescent Power and the consolidated entity. Company made four major announcements: 1) interim dividend of Rs45/share, 2) increase in holding in Noida Power from 49.55% to 72.73% (at 7.1x FY20 EV/EBITDA at a consideration of Rs4.5bn), 3) Board approval for consolidation of all distribution businesses (except Kolkata) in Eminent Electricity Distribution (a wholly-owned subsidiary), and 4) ESG ratings upgrade to 'BB'. If similar (~50%) dividend payout is maintained, dividend yield at CMP for FY21E-FY23E averages 7%. Maintain BUY with the target price unchanged at Rs851/share.

- Consolidated PAT higher, but lower volumes affect Kolkata distribution: Standalone/consolidated PAT came in higher at Rs1.8bn/Rs3.3bn, up 3.4%/24.7% YoY. Standalone revenue/EBITDA was flat YoY at Rs17.7bn/Rs4.1bn, while that for the consolidated business was up 7.2%/7.4% at Rs27bn/Rs8.9bn. Volumes at Kolkata distribution was 1.4% YoY lower. In Q3FY21, Haldia operated at a PLF of 84% (down 381bps YoY), yet its profit increased by 8.4% YoY to Rs900mn. Chandrapur operated at a PLF of 83% vs 67% YoY and continued to be profitable with PAT of Rs280mn vs loss of Rs150mn in Q3FY20. Rajasthan DFs reported PAT of Rs210mn which was 22% lower YoY, but both billing and collections normalized during the quarter to pre-covid levels. Profit of Noida Power fell 21% YoY to Rs230mn. Both demand and collections at DFs improved significantly resulting in 62% reduction in losses to Rs110mn. Malegaon DF's 9MFY21 revenue/loss came in at Rs3bn/Rs540mn.

- Rs45/share dividend announced: Company has announced an interim dividend of Rs45/share. This translates into 52% payout at FY21E EPS of Rs87. At CMP, the dividend yield is 6.6%. If the payout ratio of 50% is maintained going forward, the dividend yield averages 7% over FY21E-FY23E.

- Increases stake in Noida Power: CESC will increase its holding in Noida Power (NPCL) from 49.55% currently to 72.73%. For the 23.18% stake, CESC will pay Rs4.5bn at an EV of Rs19.5bn, implying 7.1x FY20 EBITDA of Rs2.7bn. NPCL posted a profit of Rs1.4bn in FY20 and recorded 12.5% growth in sales volumes and 17.2% growth in billed revenues. Volumes are likely to grow at 10% going forward.

- To consolidate ex-Kolkata distribution businesses into a single entity: CESC's Board has approved a proposal for consolidation of all distribution business investments (ex-Kolkata distribution) into Eminent Electricity Distribution, a wholly-owned subsidiary.

- ESG ratings upgraded to 'BB' by MSCI: CESC's approach towards improving its ESG profile paid dividends as the MSCI upgraded its ESG rating to 'BB' in its latest update.

- Maintain BUY: We maintain BUY on CESC with a target price of Rs851/share. The stock is currently trading at FY23E P/E of 6.8x and P/BV of 0.8x, and a dividend yield of 7.3%.

Shares of CESC LTD. was last trading in BSE at Rs.694.8 as compared to the previous close of Rs. 683.6. The total number of shares traded during the day was 85149 in over 4271 trades.

The stock hit an intraday high of Rs. 710 and intraday low of 689. The net turnover during the day was Rs. 59497446.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Easy Trip Planners Ltd. - IPO - Strong Financials - Reliance Securities

Bharat Forge - Initiating Coverage - Constant evolution - HDFC Securities

Mahindra Logistics - Large-ticket deal win - ICICI Securities

Company Update - Huhtamaki India - ICICI Direct

Gladiator Stocks: IndusInd Bank, VIP Industries - ICICI Direct

Warehousing demand expected to grow around 160% to reach 35 million sq. ft in 2021: JLL

Telecom - Spectrum auction: Prudent investment by Bharti Airtel - ICICI Securities

JB Chemicals & Pharmaceuticals - Analyst meet takeaways - ICICI Securities

IPO Review - MTAR Technologies Ltd - ICICI Direct

Auto Sector - Monthly Volume Round-up - Feb 21 - Decent YoY Growth Continues

Aditya Birla Fashion and Retail - Focus on scaling up new businesses - ICICI Securities

Automobiles (wholesale) - Wholesales push continues despite modest retail trends - ICICI Securities

Aditya Birla Capital - Thoughtful (inclusive) conglomerate business evolution commands premium - ICICI Securities

Jubilant Foodworks - Buying in-the-money options - ICICI Securities

Multi Commodity Exchange of India - Play on rising commodity prices? - ICICI Securities

Gladiator Stocks - Sudarshan Chemical - ICICI Direct

Monthly Commodities Outlook - March 2021 - ICICI Direct

ICICI Direct - Monthly Currency Outlook: Rupee to depreciate further towards 75.00 level...

ICICI Direct - Covid Recovery Pulse - E-way bill generation in February 2021 starts on strong note...

Company Update - Virtual JLR Investor Event - Tata Motors - ICICI Direct

Analyst Meet Update - Aditya Birla Fashion and Retail - ICICI Direct

MTAR Technologies Ltd. - IPO - Huge Opportunities from Clean Energy Bodes Well - Reliance Research

ICICI Direct Derivatives Weekly View (February 26): Failure to move above 14700 may extend declines towards 14300...

Bank: Sector Credit Trends - Slows, Yet again - HDFC Securities

Piramal Enterprises - Pharma day highlights - ICICI Securities

Polymer price tracker - PVC prices rise sharply again! - ICICI Securities

Greenply Industries - Growth returns, at an inflection point - ICICI Securities

Tata Motors - JLR future proofing itself with rapid electric transition - ICICI Securities

Dairy - Higher freight cost and increase in Global SMP prices - ICICI Securities

Analyst Meet Update - Nestlé India (Hold): Focus on product innovation, expanding rural reach - ICICI Direct

MTAR Technologies Ltd - A strong player in booming high precision engineering... - Geojit

Rollover Report for February - March 2021 : Angel Broking

Reaction from industry experts on Q3FY21 GDP numbers

M. Govinda Rao, Chief Economic Adviser, Brickwork ratings on Q3FY21 GDP numbers

Mr. Dhiraj Relli, MD & CEO, HDFC securities views on Q3FY21 GDP Growth Number

Suman Chowdhury, Chief Analytical Officer, Acuité Ratings & Research on Q3FY21 GDP

Rollover Analysis - Feb 21, 2021 - YES Securities

Consumer Durables - Demand-driven recovery continues - HDFC Securities

Cement - Demand surprises; earnings upgrade to continue - ICICI Securities

Gladiator Stocks - TeamLease Services - ICICI Direct

Gladiator Stocks - Metals to outshine post multi-year breakout... - ICICI Direct

Company Update - Sundaram Finance - ICICI Direct

Indian pharmaceutical industry to meet an ambition of US$130 billion by 2030 through innovation-led growth: EY-FICCI report

4th Industrial Conclave - Bullish undertone, favourable valuation - HDFC Securities

Sanofi India - Weak quarter; sequential improvement - ICICI Securities

Sunteck Realty - All eyes on upcoming launches - ICICI Securities

Company Update - Tata Motors - ICICI Direct

Q4CY20 Company Update - Mahindra CIE Automotive - ICICI Direct

Event Update - Hindalco - ICICI Direct

EY report launch at BioAsia 2021 - Moving the needle: Healthcare industry in a post-COVID world



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020